Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 1421208)

Published in Ann Surg on February 01, 2001

Authors

B M Clary1, M S Brady, J J Lewis, D G Coit

Author Affiliations

1: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. clary001@mc.duke.edu

Articles citing this

The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24

Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol (2008) 1.67

Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg (2013) 1.50

Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32

A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol (2009) 1.16

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol (2011) 0.97

Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int (2003) 0.91

"Stealth" melanoma cells in histology-negative sentinel lymph nodes. Am J Surg Pathol (2011) 0.90

Recent developments in plastic surgery. BMJ (2002) 0.87

Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87

Primary cutaneous melanoma of the breast: A case report. Cases J (2008) 0.85

Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer (2009) 0.84

Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging (2005) 0.84

Melanoma and sentinel nodes. Curr Surg (2004) 0.79

Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland. Ann Surg Oncol (2006) 0.78

Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol (2003) 0.77

Subungual tumors. Hand (N Y) (2012) 0.75

Acral lentiginous melanoma: a case control study and guidelines update. Case Rep Med (2011) 0.75

Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye. Ann Surg (2016) 0.75

Sentinel node biopsy as an adjunct to limb salvage surgery for epithelioid sarcoma of the hand. World J Surg Oncol (2005) 0.75

Articles cited by this

Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Cancer statistics, 1999. CA Cancer J Clin (1999) 9.18

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet (1998) 4.46

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

The orderly progression of melanoma nodal metastases. Ann Surg (1994) 2.16

Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med (1988) 2.15

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09

Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol (1998) 1.92

Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res (1995) 1.87

Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol (1998) 1.57

Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc (1986) 1.44

Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26

Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet (1988) 1.13

Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer (1993) 1.03

Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg (1999) 1.00

Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet (1985) 0.89

Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg (1992) 0.86

Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol (1998) 0.86

Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis. Melanoma Res (1995) 0.79

Articles by these authors

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91

The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87

Resection of metastatic renal cell carcinoma. J Clin Oncol (1998) 2.75

Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74

Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67

Community health worker performance in the management of multiple childhood illnesses: Siaya District, Kenya, 1997-2001. Am J Public Health (2001) 2.64

Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 2.61

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19

Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17

Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med (1999) 2.15

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06

Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03

Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest (1998) 2.02

Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01

The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97

Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97

Adult urological sarcoma. J Urol (1992) 1.94

Heteroclitic immunization induces tumor immunity. J Exp Med (1998) 1.92

Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86

Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol (2000) 1.83

Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78

Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol (1997) 1.77

Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol (1997) 1.75

Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer (2000) 1.58

A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52

The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50

The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50

Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46

Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol (1999) 1.44

The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42

Extraskeletal osteosarcoma: analysis of outcome of a rare neoplasm. Sarcoma (2000) 1.42

Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann Surg Oncol (1998) 1.35

Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg (2001) 1.32

Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer (1997) 1.31

Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg (2001) 1.29

Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer (1998) 1.27

Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol (1999) 1.26

Melanoma metastatic to stomach, small bowel, or colon. Am J Surg (1991) 1.24

Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients. Sarcoma (2000) 1.24

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer (1999) 1.21

Surgical management of Merkel cell carcinoma. Ann Surg (1999) 1.21

Epithelioid sarcoma: clinical behavior and prognostic factors of survival. Ann Surg Oncol (1997) 1.20

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer (2000) 1.20

Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys (2000) 1.20

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. Surgery (2000) 1.15

A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses. J Immunol (1999) 1.12

Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol (2001) 1.11

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10

Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer (1998) 1.09

Adult soft tissue sarcoma. Aust N Z J Surg (1999) 1.06

Desmoid tumors of the head and neck--a clinical study of a rare entity. Head Neck (2000) 1.04

Multifocal extremity sarcoma: an uncommon and controversial entity. Ann Surg Oncol (1998) 1.04

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer (2011) 1.01

Lack of lactobezoars in infants given predominantly whey protein formulas. Am J Dis Child (1982) 1.01

Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00

Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J (1996) 1.00

Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg (1999) 0.98

Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa. Infection (2013) 0.97

Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res (2001) 0.97

Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008. Int J Tuberc Lung Dis (2012) 0.97

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas. Ann Surg Oncol (1998) 0.97

Childhood melanoma survival. Cancer (1999) 0.96

Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96

Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer (2001) 0.95

Increased incidence of lactobezoars in low birth weight infants. Am J Dis Child (1979) 0.95

Major amputation for advanced malignant melanoma. Surg Gynecol Obstet (1989) 0.94

Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. Clin Cancer Res (1998) 0.94

Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis. Pediatrics (1981) 0.93

Soft tissue sarcomas of the groin: diagnosis, management, and prognosis. J Am Coll Surg (2001) 0.93

A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol (2006) 0.93

Factors associated with HIV-testing and acceptance of an offer of home-based testing by men in rural Zambia. AIDS Behav (2015) 0.92

Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects. Cytokines Cell Mol Ther (1999) 0.92

Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol (2000) 0.91

[Soft tissue sarcoma: prognostic factors and multimodal treatment]. Chirurg (2000) 0.91

Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91

Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin Cancer Res (1997) 0.91

Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketones. Biochemistry (1987) 0.91

Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase. J Med Chem (1997) 0.90

Preperitoneal repair of inguinal hernia at open radical prostatectomy. Hernia (2009) 0.89

Growth outcome and feeding practices of the very low birth weight infant (less than 1500 grams) within the first year of life. J Pediatr (1990) 0.88

Steroidal monoquaternary ammonium salts with non-depolarizing neuromuscular blocking activity. J Pharm Pharmacol (1967) 0.88

Malignant fibrous histiocytoma of the extremity. Cancer (1999) 0.87

Large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol (2000) 0.87

Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg (1992) 0.86

Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol (1997) 0.86

Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: a case report. J Surg Oncol (2000) 0.86

Redistribution of 23 kDa tubulovesicle-associated GTP-binding proteins during parietal cell stimulation. Biochem J (1991) 0.85

Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Ann Oncol (2010) 0.85

Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res (1990) 0.85